Sio Capital Management, LLC Atreca, Inc. Transaction History

Sio Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $557,064 - $1.03 Million	-113,455 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$13.0 - $19.34 $195,000 - $290,100	-15,000 Reduced 11.68%	113,455 $1.74 Million
Q4 2020 Feb 16, 2021	BUY	$13.03 - $17.09 $647,421 - $849,150	49,687 Added 63.08%	128,455 $2.08 Million
Q3 2020 Nov 16, 2020	BUY	$12.67 - $23.19 $725,294 - $1.33 Million	57,245 Added 265.97%	78,768 $1.1 Million
Q2 2020 Aug 14, 2020	SELL	$12.52 - $23.45 $322,127 - $603,345	-25,729 Reduced 54.45%	21,523 $458,000
Q1 2020 May 15, 2020	SELL	$11.4 - $27.28 $433,884 - $1.04 Million	-38,060 Reduced 44.61%	47,252 $782,000
Q4 2019 Feb 14, 2020	BUY	$9.68 - $18.67 $825,820 - $1.59 Million	85,312 New	85,312 $1.32 Million

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.